title: Effects of ketamine on context-processing performance in monkeys: a new animal model of cognitive deficits in schizophrenia.
abstract: Cognitive deficits are at the crux of why many schizophrenia patients have poor functional outcomes. One of the cognitive symptoms experienced by schizophrenia patients is a deficit in context processing, the ability to use contextual information stored in working memory to adaptively respond to subsequent stimuli. As such, context processing can be thought of as the intersection between working memory and executive control. Although deficits in context processing have been extensively characterized by neuropsychological testing in schizophrenia patients, they have never been effectively translated to an animal model of the disease. To bridge that gap, we trained monkeys to perform the same dot pattern expectancy (DPX) task, which has been used to measure context-processing deficits in human patients with schizophrenia. In the DPX task, the first stimulus in each trial provides the contextual information that subjects must remember in order to appropriately respond to the second stimulus in the trial. We found that administration of ketamine, an N-methyl-D-aspartate receptor antagonist, in monkeys caused a dose-dependent failure in context processing, replicating in monkeys the same specific pattern of errors committed by patients with schizophrenia when performing the same task. Therefore, our results provide the first evidence that context-processing dysfunction can be modeled in animals. Replicating a schizophrenia-like behavioral performance pattern in monkeys performing the same task used in humans provides a strong bridge to better understand the biological basis for this psychiatric disease and its cognitive manifestations using animal models.
authors: 1] Medical Scientist Training Program (MD/PhD), University of Minnesota, Minneapolis, MN, USA [2] Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA [3] Brain Sciences Center, VA Medical Center, Minneapolis, MN, USA.
authors: Rachael K
authors: RK
authors: Blackman
authors: Angus W
authors: AW
authors: Macdonald
authors: Matthew V
authors: MV
authors: Chafee
mesh_terms: D000818:Animals; D003072:Cognition Disorders / Q000139:chemically induced* / Q000523:psychology; D004195:Disease Models, Animal; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D007649:Ketamine / Q000494:pharmacology*; D008253:Macaca mulatta; D008297:Male; D012559:Schizophrenia / Q000139:chemically induced / Q000150:complications / Q000503:physiopathology*; D012565:Schizophrenic Psychology
chemical_list: D018691:Excitatory Amino Acid Antagonists; D007649:Ketamine
references: Neuropsychopharmacology. 2012 Feb;37(3):677-84
references: 22012475
references: Am J Psychiatry. 2005 Mar;162(3):475-84
references: 15741464
references: Schizophr Res. 1998 Sep 7;33(1-2):69-77
references: 9783346
references: Trends Neurosci. 2008 May;31(5):234-42
references: 18395805
references: Brain Res Bull. 2010 Sep 30;83(3-4):108-21
references: 20417696
references: Neuropsychopharmacology. 2003 Jan;28(1):170-81
references: 12496954
references: Neuropsychology. 2005 Nov;19(6):814-821
references: 16351357
references: Psychiatry Res. 2013 Jul 30;208(2):118-24
references: 23102922
references: Handb Exp Pharmacol. 2012;(213):367-99
references: 23027421
references: Annu Rev Neurosci. 2001;24:167-202
references: 11283309
references: Psychiatry Res. 1993 Feb;46(2):175-99
references: 8483976
references: Psychol Assess. 2010 Mar;22(1):131-41
references: 20230159
references: Arch Gen Psychiatry. 1992 Dec;49(12):975-82
references: 1449384
references: J Abnorm Psychol. 2004 Nov;113(4):556-68
references: 15535788
references: Drug Alcohol Depend. 2002 Oct 1;68(2):175-87
references: 12234647
references: Arch Gen Psychiatry. 1996 Dec;53(12):1105-12
references: 8956676
references: Psychopharmacology (Berl). 2004 Jun;174(1):111-25
references: 15205882
references: Bipolar Disord. 2007 May;9(3):230-7
references: 17430297
references: Schizophr Bull. 2000;26(1):119-36
references: 10755673
references: J Abnorm Psychol. 2005 Nov;114(4):599-611
references: 16351383
references: Am J Psychiatry. 1991 Oct;148(10):1301-8
references: 1654746
references: Neuropsychopharmacology. 2005 Oct;30(10):1861-9
references: 15841110
references: Psychopharmacology (Berl). 2010 Jun;210(3):407-18
references: 20401749
references: Schizophr Bull. 2008 Jul;34(4):619-28
references: 18487225
references: Neuropsychopharmacology. 2006 Aug;31(8):1675-81
references: 16205773
references: Schizophr Res. 2010 May;118(1-3):128-33
references: 20202795
references: Schizophr Bull. 1984;10(2):160-203
references: 6729409
references: Pharmacol Biochem Behav. 1997 Apr;56(4):789-95
references: 9130306
references: Arch Gen Psychiatry. 2011 Jul;68(7):654-64
references: 21383251
references: Schizophr Bull. 2012 Jan;38(1):104-13
references: 22199092
references: Arch Gen Psychiatry. 1998 Feb;55(2):186-8
references: 9477937
references: Schizophr Bull. 2012 Sep;38(5):920-6
references: 22987850
references: J Abnorm Psychol. 1999 Feb;108(1):120-33
references: 10066998
references: Schizophr Bull. 2012 Jan;38(1):144-52
references: 22101961
references: J Neurosci. 2012 Mar 7;32(10):3499-515
references: 22399773
references: Arch Gen Psychiatry. 2000 Dec;57(12):1139-47
references: 11115327
references: Neuroreport. 2010 Mar 31;21(5):390-4
references: 20186106
references: Psychol Rev. 1992 Jan;99(1):45-77
references: 1546118
references: Exp Brain Res. 2006 Sep;174(2):279-91
references: 16636795
references: Percept Mot Skills. 1983 Feb;56(1):99-106
references: 6844086
references: Schizophr Res. 2005 Jul 15;76(2-3):199-206
references: 15949653
references: Biol Psychiatry. 2007 May 15;61(10):1157-60
references: 16950221
references: Arch Gen Psychiatry. 1994 Mar;51(3):199-214
references: 8122957
references: Behav Brain Res. 1991 Feb 28;42(2):115-21
references: 1647781
references: Arch Gen Psychiatry. 2003 Jan;60(1):57-65
references: 12511173
references: Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):219-32
references: 15694228
references: Schizophr Bull. 2010 May;36(3):585-94
references: 18835838
references: Schizophr Bull. 2011 Sep;37(5):1048-56
references: 20185539
references: J Abnorm Psychol. 2003 Feb;112(1):132-43
references: 12653421